Sol Atriyal Apendiks Klipleme

Harrison M J, MarshallJ. Atrial fibrillation, TIAs and completed strokes. Stroke. 1984;15 (3):441–2.

Lamassa M, Di CarloA, PracucciG, BasileA M, TrefoloniG, VanniP, SpolveriS, BaruffiM C, LandiniG, GhettiA, WolfeC D, InzitariD. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke. 2001;32 (2):392–8.

Redfors B, GrayWA, LeeR J, EllenbogenK A, Bonafede M, Ben-YehudaO. Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke. JACC Clin Electrophysiol. 2017;3 (12):1369–1376.

Adderley N, RyanR, Marshall T. The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK. Br J Gen Pract. 2017;67 (662):e588–e597.

Onalan Orhan, LashevskyIlan, HamadAdel, CrystalEugene. Nonpharmacologic stroke prevention in atrial fibrillation. Expert Rev Cardiovasc Ther. 2005;3 (4):619–33.

Bedeir K, Giugliano RP, Ramlawic B. Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand. Int. J. Cardiol. 2016;222 ():615–619.

Blackshear J L, OdellJ A. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann. Thorac. Surg. 1996;61 (2):755–9.

Bedeir K, Holmes D R, Cox J L, Ramlawi B. Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation. J. Thorac. Cardiovasc. Surg. 2017;153 (5):1097–1105.

Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, HolmesD. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013;127 (6):720–9.

Salzberg SP, Plass A, Emmert MY, Desbiolles L, Alkadhi H, Grünenfelder J, Genoni M. Left atrial appendage clip occlusion: early clinical results. J. Thorac. Cardiovasc. Surg. 2010;139 (5):1269–74.

Ailawadi G, Gerdisch Marc W, Harvey RiL, Hooker R L, Damiano RJ, Salamon T, Mack MJ. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J. Thorac. Cardiovasc. Surg. 2011;142 (5):1002–9, 1009.e1.

Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in colla boration with the european association of cardio‐thoracic surgery (EACTS). Eur Heart J. 2020.

Boersma LV, Schmidt B, Betts TR, et al. EWOLUTION investigators. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri‐procedural outcomes from the EWOLU TION registry. Eur Heart J. 2016;37:2465‐2474.

Reddy VY, Mobius‐Winkler S, Miller MA, et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA plavix feasibility study with watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013;61:2551‐2556.

Saw J, Fahmy P, Azzalini L, et al. Early canadian multicenter ex perience with WATCHMAN for percutaneous left atrial appendage closure. J Cardiovasc Electrophysiol. 2017;28:396‐401.

J EA Snyder, KWhite, NBudiansky, JSmith. Left Atrial Appendage Occlusion Device: Evaluation of Surgical Implant Success and in Vivo Corrosion Performance. Surgical Science . 2012;3:28–33.

Fleerakkers JA, Hofman FN, Boersma LVA, van Putte BP. Clip the appendage, contain the clot: a small case series. HeartRhythm Case Rep. 2020;6:845‐846.

van LAAr C, Verberkmoes NJ, van Es HW, et al. Thoracoscopic left atrial appendage clipping: a multicenter cohort analysis. JACC Clin Electrophysiol. 2018;4:893‐901.